The report for Global Percutaneous Coronary Intervention Market by Market Research
Future comprises of extensive primary research along with the detail analysis of qualitative
as well as quantitative aspects by various industry experts, key opinion leaders to gain a
deeper insight of the market and industry performance.
Percutaneous Coronary Intervention (PCI) is a non-surgical procedure used to treat
narrowing of the coronary arteries of the heart by placing a stent in the contracting artery.
PCI uses imaging techniques to guide the stent to the exact location.
Considering all these factors the Percutaneous Coronary Intervention Market is expected to
reach $ 15,769 million by the end of 2023, this market is projected to growing at a CAGR of
~10.8% during 2017-2023.
The market for PCI is increasing due to rise in risk factors associated with heart diseases
such as obesity, smoking and substance abuse, fatty foods etc. The life threatening nature
of coronary heart diseases, greater reimbursement to heart diseases, the growth of
specialty hospitals etc. are driving the market for PCI. The most critical technological growth
factor however is the development of advanced stents such as drug-eluting stents (DES),
bare metal stents, bioresorbable stents and the falling cost of these stents.
The regulatory changes in the U.S. is affecting the PCI market positively. For example, the
FDI changed the class of standard balloon-tipped angioplasty catheters from Class III
medical devices to Class II devices with special controls. Thus companies can now avoid
pre-market approval (PMA) process to bring their device to the market. Thus companies will
achieve faster clearance for their devices with added advantage of less cost.
The market constraints are the high cost of the procedure, coupled with the risks involved,
the low availability of cardiac surgeons, low number of cardiac hospitals etc.
Segments: The Global Percutaneous Coronary Intervention Market is segmented on the
basis of stents. Based on the stents, the market has been segmented as drug-eluting stents
(DES), bare metal stents and bioresorbable stents. The surgery type segment is further sub
segmented into percutaneous coronary intervention (PCI), transcatheter aortic valve
implantation (TAVI/TAVR), trans-mitral valve implantation (TMVR). Similarly the cosmetic
implants segment is sub segmented into breast augmentation, buttock implants, chin &
cheek implants.
Key players of Global Percutaneous Coronary Intervention Market: Abbott Vascular,
Svelte Medical, Medtronic Plc., Boston Scientific, Sysmetis, Cardiac Dimensions, Acrostak,
Edwards Lifesciences and others.
Get Sample Copy at http://bit.ly/2Idor7O .
Regional analysis: US accounts for the maximum market share of the Global Percutaneous
Coronary Intervention Market and the market is expected to increase continuously in
coming years. This can be attributed to increasing pool of awareness and the growing
acceptability of percutaneous coronary intervention. Advancing technologies within the
percutaneous coronary intervention such as advanced silicone and polymer implants is also
driving the market. However there is a definite shift of percutaneous coronary intervention
market to Asia pacific and Latin America with the most active part played by medical
tourism industry.
Intended Audience
Global Percutaneous coronary intervention solutions providers, manufacturers &
suppliers
Research and development (R&D) companies
Market research and consulting service providers
Academic institutes and universities
Top Reasons to Buy the Reports: